| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 06/29/2011 | CN102106887A Medicament for treating respiratory system diseases |
| 06/29/2011 | CN102106886A Method for extracting effective components of echinacea purpurea by utilizing microwave technology |
| 06/29/2011 | CN102106884A Medicinal composition having immunity-regulating function |
| 06/29/2011 | CN102106848A Pharmaceutical composition for treating non-small cell lung cancer (NSCLC) and application thereof, kit and package part |
| 06/29/2011 | CN102106843A Slow-release lung targeted microcapsule preparation of florfenicol and preparation method thereof |
| 06/29/2011 | CN102106823A Resveratrol composite fine particle preparation process applying supercritical fluid crystallization technology |
| 06/29/2011 | CN102106813A Sodium new neohouttuyfonate injection and preparation method and application thereof |
| 06/29/2011 | CN102106420A Method for processing camellia nitidissima granules |
| 06/29/2011 | CN101862442B Cough-relieving Chinese medicinal composition and preparation method thereof |
| 06/29/2011 | CN101843829B Chinese medicament for treating pulmonary heart diseases |
| 06/29/2011 | CN101816736B Chinese medicament capsule for curing nasosinusitis |
| 06/29/2011 | CN101697996B Chinese herbal medicinal composition for externally treating allergic rhinitis |
| 06/29/2011 | CN101653552B Smoke-quitting alexeteric traditional Chinese medicine preparation and production method thereof |
| 06/29/2011 | CN101642483B Microwave treatment and storage method of snakegourd fruits |
| 06/29/2011 | CN101627969B Novel curcumin self-emulsifying drug delivery system and preparation method thereof |
| 06/29/2011 | CN101618053B Preparation process of isatis root medical solution |
| 06/29/2011 | CN101596270B Medicine for treating chronic pharyngitis and preparation method thereof |
| 06/29/2011 | CN101518580B Pharmaceutical composition for clearing heat and releasing toxin as well as preparation method and application thereof |
| 06/29/2011 | CN101474371B Method for preparing Chinese medicine for treating phlegm-heat stagnated in lung type cough |
| 06/29/2011 | CN101411804B Mixture for clearing lung-heat and preparation method thereof |
| 06/29/2011 | CN101361801B Qiancao Naomaitong medicine for treating apoplexy or the like and preparation method thereof |
| 06/29/2011 | CN101243088B P38 map kinase inhibitors and methods for using the same |
| 06/29/2011 | CN101049502B Antigen arrays presenting il-5, il-3 or eotaxin for treatment of allergic eosinophilic diseases |
| 06/28/2011 | US7968716 Caspase inhibitors and uses thereof |
| 06/28/2011 | US7968692 Nutrients, animal feeds, cosmetics; elongation of polyunsaturated fatty acid |
| 06/28/2011 | US7968680 Polynucleotides encoding members of the human B lymphocyte activation antigen B7 family and polypeptides encoded thereby |
| 06/28/2011 | US7968556 Heteroaryl compounds, compositions thereof, and methods of treatment therewith |
| 06/28/2011 | US7968547 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 06/28/2011 | US7968528 Choline-silicic acid complex with osmolytes and divalent trace elements |
| 06/28/2011 | US7968523 Purified rat apoptosis-specific eucaryotic initiation Factor-5A (eIF-5A) and deoxyhypusine synthase nucleic acids and polypeptides |
| 06/28/2011 | US7968284 Modified polypeptides stabilized in a desired conformation and methods for producing same |
| 06/28/2011 | US7968120 Modified release dosage forms |
| 06/28/2011 | CA2649083C 2,6-substituted-4-monosubstituted amino-pyrimidine as prostaglandin d2 receptor antagonists |
| 06/28/2011 | CA2635196C Glucocorticoid receptor modulators |
| 06/28/2011 | CA2494613C Pyrrolidinedione substituted piperidine-phthalazones as pde4 inhibitors |
| 06/28/2011 | CA2467672C Chemokine receptor antagonists and methods of use therefor |
| 06/28/2011 | CA2413086C Benzothiazole derivatives |
| 06/28/2011 | CA2315976C Serine protease inhibitors |
| 06/23/2011 | WO2011075631A1 Substituted benzothiazole and benzoxazole derivatives useful as inhibitors of dpp-1 |
| 06/23/2011 | WO2011075596A1 Crystalline forms of certain 3-phenyl-pyrazole derivatives as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto |
| 06/23/2011 | WO2011075517A1 Aminopyrimidines as syk inhibitors |
| 06/23/2011 | WO2011075515A1 Aminopyrimidines as syk inhibitors |
| 06/23/2011 | WO2011073662A1 Combination of a benzoxazinone and a further agent for treating respiratory diseases |
| 06/23/2011 | WO2011073647A1 Therapeutic combinations of theobromine and an antihistamine |
| 06/23/2011 | WO2011073646A1 Combination of theobromine with a decongestant and its use for the treatment of cough |
| 06/23/2011 | WO2011073277A1 PIPERIDINE ARYL SULFONAMIDE DERIVATIVES AS Kv1.3 MODULATORS |
| 06/23/2011 | WO2011073276A1 Benzoxazine aryl sulfonamide derivatives as kv1.3 modulators |
| 06/23/2011 | WO2011073273A1 Benzoxazine aryl sulfonamide derivatives as kv1.3 modulators |
| 06/23/2011 | WO2011073269A1 Piperidine aryl sulfonamide derivatives as kv1.3 modulators |
| 06/23/2011 | WO2011073231A1 3,4,4A,10B-TETRAHYDRO-1H-THIOPYRANO-[4, 3-c] ISOQUINOLINE DERIVATIVES |
| 06/23/2011 | WO2011073180A1 Single variable domain antibodies against ox40l, constructs and therapeutic use |
| 06/23/2011 | US20110154521 Transgenic animals expressing antibodies specific for genes of interest and uses thereof |
| 06/23/2011 | US20110152374 Biphenyloxyacetic Acid Derivatives for the Treatment of Respiratory Disease |
| 06/23/2011 | US20110152338 Cycloalkane[b]indole antagonists of prostaglandin d2 receptors |
| 06/23/2011 | US20110152326 Substituted aryloxoethyl cyclopropanecarboxamide compounds as vr1 receptor antagonists |
| 06/23/2011 | US20110152321 Bicyclic derivatives useful as inhibitors of dpp-1 |
| 06/23/2011 | US20110152318 Novel compounds, isomer thereof, or pharmaceutically acceptable salts thereof as vanilloid receptor antagonist and pharmaceutical compositions containing the same |
| 06/23/2011 | US20110152316 3,4-substituted piperidine derivatives as renin inhibitors |
| 06/23/2011 | US20110152314 Use of tenatoprazole for the treatment of gastroesophageal reflux disease |
| 06/23/2011 | US20110152294 Use of osmolytes obtained from extremophilic bacteria for the production of inhalable medicaments for the prophylaxis and treatment of pulmonary and cardiovascular diseases and an inhalation device comprising osmolyte as active agent component |
| 06/23/2011 | US20110152291 Novel aromatic compounds and their use in medical applications |
| 06/23/2011 | US20110152290 Acylamino-substituted fused cyclopentanecarboxylic acid derivatives and their use as pharmaceuticals |
| 06/23/2011 | US20110152287 Substituted benzothiazole and benzoxazole derivatives useful as inhibitors of dpp-1 |
| 06/23/2011 | US20110152283 Crystalline pimobendan, process for the preparation thereof, pharmaceutical composition and use |
| 06/23/2011 | US20110152276 Substituted pyrrolo[2,3-d]pyrimidines as antifolates |
| 06/23/2011 | US20110152273 Fused heteroaromatic pyrrolidinones |
| 06/23/2011 | US20110152271 Compositions and methods for ophthalmic delivery of nasal decongestants |
| 06/23/2011 | US20110152259 Nitrogen-containing heterocyclic compounds and methods of use thereof |
| 06/23/2011 | US20110152242 2,3-Substituted Fused Pyrimidin -4 (3H)-Ones as VR1 Antagonists |
| 06/23/2011 | US20110152241 Novel compounds as receptor modulators with therapeutic utility |
| 06/23/2011 | US20110152238 Pharmaceutical compounds |
| 06/23/2011 | US20110152236 Azetidine polysubstituted compounds, preparation thereof, and therapeutic application thereof |
| 06/23/2011 | US20110152234 Novel Compounds |
| 06/23/2011 | US20110152228 Sprayable pharmaceutical compositions comprising a corticoid and an oily phase |
| 06/23/2011 | US20110152227 Deuterium labelled derivatives of 3-(2-hydroxy-5-methyphenyl)-n,n-diisopropyl-3-phenylpropylamine and methods of use thereof |
| 06/23/2011 | US20110152223 Therapeutic agent for anca-related vasculitis |
| 06/23/2011 | US20110152217 Polymorphs of (s)-3-aminomethyl-7-(3-hydroxy-propoxy)-3h-benzo[c][1,2]oxaborol-1-ol |
| 06/23/2011 | US20110152209 Core 2 GlcNAc-T Inhibitors |
| 06/23/2011 | US20110152174 Inhibition of secretion from non-neuronal cells |
| 06/23/2011 | US20110152173 TNF-a ANTAGONIST MULTI-TARGET BINDING PROTEINS |
| 06/23/2011 | US20110152172 Methods of Treating Pulmonary Diseases and Disorders by Modulating Calcium/Calmodulin Dependent Protein Kinase II Activity |
| 06/23/2011 | US20110152171 Histamine binding protein |
| 06/23/2011 | US20110152169 Sparc anti-inflammatory activity and uses thereof |
| 06/23/2011 | US20110152168 Antiadhesive carbohydrates |
| 06/23/2011 | US20110151025 Compositions Comprising N-Halogenated or N,N-Dihalogenated Amine for Treatment and Prophylaxis of Bronchopulmonary Infections |
| 06/23/2011 | US20110151010 Anti-snoring treatment comprising positively charged multilamellar microparticles |
| 06/23/2011 | US20110150981 Compounds for Use in Therapy |
| 06/23/2011 | US20110150975 Treatment of Mammalian Physiological Reaction of IgE Antibodies Present in Said Mammal Upon Contact With the Corresponding Antigen |
| 06/23/2011 | US20110150929 SARS vaccine compositions and methods of making and using them |
| 06/23/2011 | US20110150884 Crystalline composition of gm-csf/gm-csfr |
| 06/23/2011 | US20110150873 Anti-inflammatory compositions and combinations |
| 06/23/2011 | US20110150864 Substituted aminothiazolone indazoles as estrogen related receptor-alpha modulators |
| 06/23/2011 | US20110150863 Modulation of immunostimulatory properties of oligonucleotide-based compounds by utilizing modified immunostimulatory dinucleotides |
| 06/23/2011 | US20110150834 Crth2 modulators |
| 06/23/2011 | US20110150833 Benzopyrans and analogs as rho kinase inhibitors |
| 06/23/2011 | US20110150785 Light Inhibitors For Asthma, Lung and Airway Inflammation, Respiratory, Interstitial, Pulmonary and Fibrotic Disease Treatment |
| 06/23/2011 | US20110150784 Combination therapy for copd |
| 06/23/2011 | US20110150783 Aerosol formulation for copd |
| 06/23/2011 | US20110150782 Combination therapy for copd |
| 06/23/2011 | US20110150763 Triazine derivatives and their therapeutical applications |